Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women
NCT02717494Phase 2Completed
- Sponsor
- Westat
- Start
- Mar 2016
- Primary completion
- Nov 2018
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of 10-valent pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine in pneumococcal infection, sponsored by Westat. Started Mar 2016; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02717494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717494.